Baxter International Inc. Logo

Baxter International Inc.

BTL.DE

(1.0)
Stock Price

58,80 EUR

17.14% ROA

35.03% ROE

12.6x PER

Market Cap.

32.490.941.603,92 EUR

173.38% DER

0% Yield

17.79% NPM

Baxter International Inc. Stock Analysis

Baxter International Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Baxter International Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (40.85%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 PBV

The stock's elevated P/BV ratio (3.98x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

4 DER

The company has a high debt to equity ratio (209%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (37), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Baxter International Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Baxter International Inc. Technical Stock Analysis
# Analysis Recommendation

Baxter International Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Baxter International Inc. Revenue
Year Revenue Growth
1985 2.355.000.000
1986 5.543.000.000 57.51%
1987 6.223.000.000 10.93%
1988 6.861.000.000 9.3%
1989 7.399.000.000 7.27%
1990 8.100.000.000 8.65%
1991 8.921.000.000 9.2%
1992 8.471.000.000 -5.31%
1993 8.879.000.000 4.6%
1994 9.324.000.000 4.77%
1995 5.048.000.000 -84.71%
1996 5.438.000.000 7.17%
1997 6.138.000.000 11.4%
1998 6.599.000.000 6.99%
1999 6.380.000.000 -3.43%
2000 6.896.000.000 7.48%
2001 7.663.000.000 10.01%
2002 8.110.000.000 5.51%
2003 8.916.000.000 9.04%
2004 9.509.000.000 6.24%
2005 9.849.000.000 3.45%
2006 10.378.000.000 5.1%
2007 11.263.000.000 7.86%
2008 12.348.000.000 8.79%
2009 12.562.000.000 1.7%
2010 12.843.000.000 2.19%
2011 13.893.000.000 7.56%
2012 14.190.000.000 2.09%
2013 15.259.000.000 7.01%
2014 16.671.000.000 8.47%
2015 9.968.000.000 -67.25%
2016 10.163.000.000 1.92%
2017 10.561.000.000 3.77%
2018 11.127.000.000 5.09%
2019 11.362.000.000 2.07%
2020 11.673.000.000 2.66%
2021 12.784.000.000 8.69%
2022 15.113.000.000 15.41%
2023 14.832.000.000 -1.89%
2023 14.813.000.000 -0.13%
2024 14.368.000.000 -3.1%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Baxter International Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 343.000.000 100%
1995 345.000.000 0.58%
1996 340.000.000 -1.47%
1997 392.000.000 13.27%
1998 379.000.000 -3.43%
1999 332.000.000 -14.16%
2000 379.000.000 12.4%
2001 427.000.000 11.24%
2002 501.000.000 14.77%
2003 553.000.000 9.4%
2004 517.000.000 -6.96%
2005 533.000.000 3%
2006 614.000.000 13.19%
2007 760.000.000 19.21%
2008 868.000.000 12.44%
2009 917.000.000 5.34%
2010 915.000.000 -0.22%
2011 946.000.000 3.28%
2012 1.156.000.000 18.17%
2013 1.246.000.000 7.22%
2014 1.421.000.000 12.32%
2015 603.000.000 -135.66%
2016 647.000.000 6.8%
2017 617.000.000 -4.86%
2018 655.000.000 5.8%
2019 595.000.000 -10.08%
2020 521.000.000 -14.2%
2021 534.000.000 2.43%
2022 605.000.000 11.74%
2023 664.000.000 8.89%
2023 667.000.000 0.45%
2024 704.000.000 5.26%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Baxter International Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 657.000.000
1986 1.534.000.000 57.17%
1987 1.550.000.000 1.03%
1988 1.749.000.000 11.38%
1989 1.811.000.000 3.42%
1990 2.541.000.000 28.73%
1991 2.182.000.000 -16.45%
1992 2.196.000.000 0.64%
1993 2.983.000.000 26.38%
1994 1.859.000.000 -60.46%
1995 1.084.000.000 -71.49%
1996 1.142.000.000 5.08%
1997 1.356.000.000 15.78%
1998 1.426.000.000 4.91%
1999 1.311.000.000 -8.77%
2000 1.385.000.000 5.34%
2001 1.469.000.000 5.72%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 3.324.000.000 100%
2013 0 0%
2014 4.029.000.000 100%
2015 0 0%
2016 0 0%
2017 33.000.000 100%
2018 -48.000.000 168.75%
2019 3.290.000.000 101.46%
2020 2.469.000.000 -33.25%
2021 2.878.000.000 14.21%
2022 3.862.000.000 25.48%
2023 0 0%
2023 3.896.000.000 100%
2024 3.980.000.000 2.11%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Baxter International Inc. EBITDA
Year EBITDA Growth
1985 377.000.000
1986 809.000.000 53.4%
1987 760.000.000 -6.45%
1988 1.095.000.000 30.59%
1989 1.289.000.000 15.05%
1990 747.000.000 -72.56%
1991 1.454.000.000 48.62%
1992 1.291.000.000 -12.63%
1993 456.000.000 -183.11%
1994 1.562.000.000 70.81%
1995 1.352.000.000 -15.53%
1996 1.449.000.000 6.69%
1997 921.000.000 -57.33%
1998 1.168.000.000 21.15%
1999 1.442.000.000 19%
2000 1.484.000.000 2.83%
2001 1.461.000.000 -1.57%
2002 1.652.000.000 11.56%
2003 1.769.000.000 6.61%
2004 1.135.000.000 -55.86%
2005 2.140.000.000 46.96%
2006 2.420.000.000 11.57%
2007 2.819.000.000 14.15%
2008 3.230.000.000 12.72%
2009 3.479.000.000 7.16%
2010 2.683.000.000 -29.67%
2011 3.539.000.000 24.19%
2012 3.714.000.000 4.71%
2013 3.527.000.000 -5.3%
2014 4.162.000.000 15.26%
2015 1.908.000.000 -118.13%
2016 5.842.000.000 67.34%
2017 2.056.000.000 -184.14%
2018 2.565.000.000 19.84%
2019 1.765.000.000 -45.33%
2020 1.426.000.000 -23.77%
2021 1.669.000.000 14.56%
2022 854.000.000 -95.43%
2023 -176.000.000 585.23%
2023 1.751.000.000 110.05%
2024 2.336.000.000 25.04%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Baxter International Inc. Gross Profit
Year Gross Profit Growth
1985 1.056.000.000
1986 2.302.000.000 54.13%
1987 2.556.000.000 9.94%
1988 2.829.000.000 9.65%
1989 3.013.000.000 6.11%
1990 3.286.000.000 8.31%
1991 3.697.000.000 11.12%
1992 3.688.000.000 -0.24%
1993 3.716.000.000 0.75%
1994 3.749.000.000 0.88%
1995 2.579.000.000 -45.37%
1996 2.741.000.000 5.91%
1997 3.151.000.000 13.01%
1998 3.350.000.000 5.94%
1999 3.165.000.000 -5.85%
2000 3.437.000.000 7.91%
2001 3.436.000.000 -0.03%
2002 3.792.000.000 9.39%
2003 3.965.000.000 4.36%
2004 3.915.000.000 -1.28%
2005 4.093.000.000 4.35%
2006 4.737.000.000 13.6%
2007 5.519.000.000 14.17%
2008 6.130.000.000 9.97%
2009 6.525.000.000 6.05%
2010 5.958.000.000 -9.52%
2011 7.046.000.000 15.44%
2012 7.301.000.000 3.49%
2013 7.595.000.000 3.87%
2014 8.157.000.000 6.89%
2015 4.146.000.000 -96.74%
2016 4.110.000.000 -0.88%
2017 4.462.000.000 7.89%
2018 4.781.000.000 6.67%
2019 4.761.000.000 -0.42%
2020 4.587.000.000 -3.79%
2021 5.105.000.000 10.15%
2022 5.397.000.000 5.41%
2023 4.468.000.000 -20.79%
2023 4.975.000.000 10.19%
2024 5.548.000.000 10.33%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Baxter International Inc. Net Profit
Year Net Profit Growth
1985 137.000.000
1986 219.000.000 37.44%
1987 323.000.000 32.2%
1988 388.000.000 16.75%
1989 446.000.000 13%
1990 40.000.000 -1015%
1991 591.000.000 93.23%
1992 441.000.000 -34.01%
1993 -198.000.000 322.73%
1994 596.000.000 133.22%
1995 649.000.000 8.17%
1996 669.000.000 2.99%
1997 300.000.000 -123%
1998 315.000.000 4.76%
1999 797.000.000 60.48%
2000 740.000.000 -7.7%
2001 612.000.000 -20.92%
2002 778.000.000 21.34%
2003 881.000.000 11.69%
2004 388.000.000 -127.06%
2005 956.000.000 59.41%
2006 1.396.000.000 31.52%
2007 1.707.000.000 18.22%
2008 2.014.000.000 15.24%
2009 2.205.000.000 8.66%
2010 1.420.000.000 -55.28%
2011 2.224.000.000 36.15%
2012 2.326.000.000 4.39%
2013 2.012.000.000 -15.61%
2014 2.497.000.000 19.42%
2015 968.000.000 -157.95%
2016 4.965.000.000 80.5%
2017 717.000.000 -592.47%
2018 1.624.000.000 55.85%
2019 1.001.000.000 -62.24%
2020 1.102.000.000 9.17%
2021 1.284.000.000 14.17%
2022 -2.421.000.000 153.04%
2023 10.032.000.000 124.13%
2023 2.656.000.000 -277.71%
2024 148.000.000 -1694.59%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Baxter International Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 0
1986 0 0%
1987 1 0%
1988 1 0%
1989 1 0%
1990 0 0%
1991 1 100%
1992 1 0%
1993 0 0%
1994 1 100%
1995 1 0%
1996 1 0%
1997 1 0%
1998 1 0%
1999 1 100%
2000 1 0%
2001 1 0%
2002 1 0%
2003 1 0%
2004 1 0%
2005 2 100%
2006 2 50%
2007 3 0%
2008 3 33.33%
2009 4 0%
2010 2 -50%
2011 4 33.33%
2012 4 25%
2013 4 -33.33%
2014 5 25%
2015 2 -300%
2016 9 88.89%
2017 1 -800%
2018 3 66.67%
2019 2 -200%
2020 2 50%
2021 3 0%
2022 -5 150%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Baxter International Inc. Free Cashflow
Year Free Cashflow Growth
1985 0
1986 0 0%
1988 0 0%
1989 287.000.000 100%
1990 429.000.000 33.1%
1991 237.000.000 -81.01%
1992 226.000.000 -4.87%
1993 249.000.000 9.24%
1994 814.000.000 69.41%
1995 937.000.000 13.13%
1996 395.000.000 -137.22%
1997 120.000.000 -229.17%
1998 395.000.000 69.62%
1999 452.000.000 12.61%
2000 566.000.000 20.14%
2001 362.000.000 -56.35%
2002 345.000.000 -4.93%
2003 636.000.000 45.75%
2004 822.000.000 22.63%
2005 1.106.000.000 25.68%
2006 1.657.000.000 33.25%
2007 1.613.000.000 -2.73%
2008 1.561.000.000 -3.33%
2009 1.895.000.000 17.63%
2010 2.040.000.000 7.11%
2011 1.857.000.000 -9.85%
2012 1.945.000.000 4.52%
2013 1.673.000.000 -16.26%
2014 1.317.000.000 -27.03%
2015 736.000.000 -78.94%
2016 905.000.000 18.67%
2017 1.203.000.000 24.77%
2018 1.415.000.000 14.98%
2019 1.408.000.000 -0.5%
2020 1.159.000.000 -21.48%
2021 1.479.000.000 21.64%
2022 532.000.000 -178.01%
2023 191.000.000 -178.53%
2023 1.034.000.000 81.53%
2024 -19.000.000 5542.11%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Baxter International Inc. Operating Cashflow
Year Operating Cashflow Growth
1985 0
1986 0 0%
1988 0 0%
1989 618.000.000 100%
1990 796.000.000 22.36%
1991 769.000.000 -3.51%
1992 763.000.000 -0.79%
1993 765.000.000 0.26%
1994 1.316.000.000 41.87%
1995 1.336.000.000 1.5%
1996 793.000.000 -68.47%
1997 616.000.000 -28.73%
1998 991.000.000 37.84%
1999 1.083.000.000 8.49%
2000 1.214.000.000 10.79%
2001 1.149.000.000 -5.66%
2002 1.193.000.000 3.69%
2003 1.425.000.000 16.28%
2004 1.380.000.000 -3.26%
2005 1.550.000.000 10.97%
2006 2.183.000.000 29%
2007 2.305.000.000 5.29%
2008 2.515.000.000 8.35%
2009 2.909.000.000 13.54%
2010 3.003.000.000 3.13%
2011 2.817.000.000 -6.6%
2012 3.106.000.000 9.3%
2013 3.198.000.000 2.88%
2014 3.215.000.000 0.53%
2015 1.647.000.000 -95.2%
2016 1.624.000.000 -1.42%
2017 1.837.000.000 11.59%
2018 2.096.000.000 12.36%
2019 2.104.000.000 0.38%
2020 1.868.000.000 -12.63%
2021 2.222.000.000 15.93%
2022 1.211.000.000 -83.48%
2023 365.000.000 -231.78%
2023 1.726.000.000 78.85%
2024 163.000.000 -958.9%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Baxter International Inc. Capital Expenditure
Year Capital Expenditure Growth
1985 0
1986 0 0%
1988 0 0%
1989 331.000.000 100%
1990 367.000.000 9.81%
1991 532.000.000 31.02%
1992 537.000.000 0.93%
1993 516.000.000 -4.07%
1994 502.000.000 -2.79%
1995 399.000.000 -25.81%
1996 398.000.000 -0.25%
1997 496.000.000 19.76%
1998 596.000.000 16.78%
1999 631.000.000 5.55%
2000 648.000.000 2.62%
2001 787.000.000 17.66%
2002 848.000.000 7.19%
2003 789.000.000 -7.48%
2004 558.000.000 -41.4%
2005 444.000.000 -25.68%
2006 526.000.000 15.59%
2007 692.000.000 23.99%
2008 954.000.000 27.46%
2009 1.014.000.000 5.92%
2010 963.000.000 -5.3%
2011 960.000.000 -0.31%
2012 1.161.000.000 17.31%
2013 1.525.000.000 23.87%
2014 1.898.000.000 19.65%
2015 911.000.000 -108.34%
2016 719.000.000 -26.7%
2017 634.000.000 -13.41%
2018 681.000.000 6.9%
2019 696.000.000 2.16%
2020 709.000.000 1.83%
2021 743.000.000 4.58%
2022 679.000.000 -9.43%
2023 174.000.000 -290.23%
2023 692.000.000 74.86%
2024 182.000.000 -280.22%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Baxter International Inc. Equity
Year Equity Growth
1985 2.082.000.000
1986 2.490.000.000 16.39%
1987 2.833.000.000 12.11%
1988 3.096.000.000 8.49%
1989 4.246.000.000 27.08%
1990 4.092.000.000 -3.76%
1991 4.373.000.000 6.43%
1992 3.795.000.000 -15.23%
1993 3.185.000.000 -19.15%
1994 3.720.000.000 14.38%
1995 3.704.000.000 -0.43%
1996 2.504.000.000 -47.92%
1997 2.619.000.000 4.39%
1998 2.839.000.000 7.75%
1999 3.348.000.000 15.2%
2000 2.659.000.000 -25.91%
2001 3.757.000.000 29.23%
2002 2.939.000.000 -27.83%
2003 3.323.000.000 11.56%
2004 3.705.000.000 10.31%
2005 4.299.000.000 13.82%
2006 6.272.000.000 31.46%
2007 6.916.000.000 9.31%
2008 6.229.000.000 -11.03%
2009 7.191.000.000 13.38%
2010 6.567.000.000 -9.5%
2011 6.585.000.000 0.27%
2012 6.938.000.000 5.09%
2013 8.463.000.000 18.02%
2014 8.120.000.000 -4.22%
2015 8.846.000.000 8.21%
2016 8.290.000.000 -6.71%
2017 9.124.000.000 9.14%
2018 7.794.000.000 -17.06%
2019 7.912.000.000 1.49%
2020 8.726.000.000 9.33%
2021 9.121.000.000 4.33%
2022 5.895.000.000 -54.72%
2023 8.468.000.000 30.38%
2023 8.166.000.000 -3.7%
2024 8.235.000.000 0.84%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Baxter International Inc. Assets
Year Assets Growth
1985 6.839.000.000
1986 7.068.000.000 3.24%
1987 7.638.000.000 7.46%
1988 8.550.000.000 10.67%
1989 8.503.000.000 -0.55%
1990 8.517.000.000 0.16%
1991 9.340.000.000 8.81%
1992 9.155.000.000 -2.02%
1993 10.545.000.000 13.18%
1994 10.002.000.000 -5.43%
1995 9.437.000.000 -5.99%
1996 7.596.000.000 -24.24%
1997 8.707.000.000 12.76%
1998 10.085.000.000 13.66%
1999 9.644.000.000 -4.57%
2000 8.733.000.000 -10.43%
2001 10.343.000.000 15.57%
2002 12.478.000.000 17.11%
2003 13.779.000.000 9.44%
2004 14.147.000.000 2.6%
2005 12.727.000.000 -11.16%
2006 14.686.000.000 13.34%
2007 15.294.000.000 3.98%
2008 15.405.000.000 0.72%
2009 17.354.000.000 11.23%
2010 17.489.000.000 0.77%
2011 19.073.000.000 8.3%
2012 20.390.000.000 6.46%
2013 25.869.000.000 21.18%
2014 25.917.000.000 0.19%
2015 20.975.000.000 -23.56%
2016 15.546.000.000 -34.92%
2017 17.111.000.000 9.15%
2018 15.641.000.000 -9.4%
2019 18.193.000.000 14.03%
2020 20.019.000.000 9.12%
2021 33.521.000.000 40.28%
2022 28.287.000.000 -18.5%
2023 28.276.000.000 -0.04%
2023 30.656.000.000 7.76%
2024 27.788.000.000 -10.32%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Baxter International Inc. Liabilities
Year Liabilities Growth
1985 4.757.000.000
1986 4.578.000.000 -3.91%
1987 4.805.000.000 4.72%
1988 5.454.000.000 11.9%
1989 4.257.000.000 -28.12%
1990 4.425.000.000 3.8%
1991 4.967.000.000 10.91%
1992 5.360.000.000 7.33%
1993 7.360.000.000 27.17%
1994 6.282.000.000 -17.16%
1995 5.733.000.000 -9.58%
1996 5.092.000.000 -12.59%
1997 6.088.000.000 16.36%
1998 7.246.000.000 15.98%
1999 6.296.000.000 -15.09%
2000 6.074.000.000 -3.65%
2001 6.586.000.000 7.77%
2002 9.539.000.000 30.96%
2003 10.456.000.000 8.77%
2004 10.442.000.000 -0.13%
2005 8.428.000.000 -23.9%
2006 8.414.000.000 -0.17%
2007 8.378.000.000 -0.43%
2008 9.176.000.000 8.7%
2009 9.934.000.000 7.63%
2010 10.693.000.000 7.1%
2011 12.245.000.000 12.67%
2012 13.412.000.000 8.7%
2013 17.383.000.000 22.84%
2014 17.761.000.000 2.13%
2015 12.110.000.000 -46.66%
2016 7.266.000.000 -66.67%
2017 7.995.000.000 9.12%
2018 7.825.000.000 -2.17%
2019 10.281.000.000 23.89%
2020 11.293.000.000 8.96%
2021 24.400.000.000 53.72%
2022 22.392.000.000 -8.97%
2023 19.808.000.000 -13.05%
2023 22.490.000.000 11.93%
2024 19.553.000.000 -15.02%

Baxter International Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
28.79
Net Income per Share
5.12
Price to Earning Ratio
12.6x
Price To Sales Ratio
2.18x
POCF Ratio
23.67
PFCF Ratio
45.89
Price to Book Ratio
4.08
EV to Sales
2.93
EV Over EBITDA
27.78
EV to Operating CashFlow
30.95
EV to FreeCashFlow
61.63
Earnings Yield
0.08
FreeCashFlow Yield
0.02
Market Cap
32,49 Bil.
Enterprise Value
43,63 Bil.
Graham Number
42.66
Graham NetNet
-25.4

Income Statement Metrics

Net Income per Share
5.12
Income Quality
-18.8
ROE
0.35
Return On Assets
0.1
Return On Capital Employed
0.02
Net Income per EBT
-2649
EBT Per Ebit
-0
Ebit per Revenue
0.03
Effective Tax Rate
-29

Margins

Sales, General, & Administrative to Revenue
0.07
Research & Developement to Revenue
0.05
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.34
Operating Profit Margin
0.03
Pretax Profit Margin
-0
Net Profit Margin
0.18

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0.22
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
2.73
Free CashFlow per Share
1.37
Capex to Operating CashFlow
-0.5
Capex to Revenue
-0.05
Capex to Depreciation
-0.55
Return on Invested Capital
0.6
Return on Tangible Assets
0.17
Days Sales Outstanding
61.79
Days Payables Outstanding
49.47
Days of Inventory on Hand
111.23
Receivables Turnover
5.91
Payables Turnover
7.38
Inventory Turnover
3.28
Capex per Share
-1.36

Balance Sheet

Cash per Share
5,85
Book Value per Share
15,80
Tangible Book Value per Share
-7.93
Shareholders Equity per Share
15.8
Interest Debt per Share
28.32
Debt to Equity
1.73
Debt to Assets
0.51
Net Debt to EBITDA
7.09
Current Ratio
1.48
Tangible Asset Value
-4,10 Bil.
Net Current Asset Value
-10,15 Bil.
Invested Capital
1.73
Working Capital
3,04 Bil.
Intangibles to Total Assets
0.44
Average Receivables
2,63 Bil.
Average Payables
1,29 Bil.
Average Inventory
2906000000
Debt to Market Cap
0.44

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Baxter International Inc. Dividends
Year Dividends Growth
2008 1
2009 1 100%
2010 1 0%
2011 1 0%
2012 2 0%
2013 2 0%
2014 2 50%
2015 1 -100%
2016 1 0%
2017 1 0%
2018 0 0%
2019 0 0%
2020 1 0%
2021 1 100%
2022 1 0%

Baxter International Inc. Profile

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

CEO
Mr. Jose E. Almeida
Employee
60.000
Address
One Baxter Parkway
Deerfield, 60015

Baxter International Inc. Executives & BODs

Baxter International Inc. Executives & BODs
# Name Age
1 Ms. Heather Knight
Executive Vice President & Group President of Medical Products and Therapies
70
2 Ms. Jeanne K. Mason Ph.D.
?Executive Vice President & Chief Human Resources Officer
70
3 Ms. Clare Trachtman
Vice President of Investor Relations
70
4 Ms. Stacey Eisen
?Senior Vice President, Chief Communications Officer & Corporate Marketing?
70
5 Mr. Joel T. Grade
Executive Vice President & Chief Financial Officer
70
6 Mr. Alok Sonig B.E., Mba
Executive Vice President & Group President of Pharmaceuticals
70
7 Mr. Jose E. Almeida
Chairman of the Board, President & Chief Executive Officer
70
8 Mr. David S. Rosenbloom
Executive Vice President & General Counsel
70
9 Mr. Christopher A. Toth
Executive Vice President & Group President of Kidney Care
70
10 Ms. Tobi Karchmer M.D., M.S.
Senior Vice President and Chief Medical & Scientific Officer
70

Baxter International Inc. Competitors